Document Detail

Policy statement on folic acid and neural tube defects.
MedLine Citation:
PMID:  21552133     Owner:  NLM     Status:  MEDLINE    
It now recognized that the use of folate fortification and/or supplementation before initiation of pregnancy can impact the risk of the fetus developing a neural tube defect. This document serves to update the policy statement issued by the American College of Medical Genetics and published in 2005.
Helga V Toriello;
Related Documents :
287783 - Plasma female sex-hormone levels and gingivitis in pregnancy.
21239703 - Prediction of the fetal status in noninvasive management of alloimmune thrombocytopenia.
15485113 - Ivig in aps pregnancy.
Publication Detail:
Type:  Journal Article; Practice Guideline    
Journal Detail:
Title:  Genetics in medicine : official journal of the American College of Medical Genetics     Volume:  13     ISSN:  1530-0366     ISO Abbreviation:  Genet. Med.     Publication Date:  2011 Jun 
Date Detail:
Created Date:  2011-06-09     Completed Date:  2011-09-28     Revised Date:  2011-10-12    
Medline Journal Info:
Nlm Unique ID:  9815831     Medline TA:  Genet Med     Country:  United States    
Other Details:
Languages:  eng     Pagination:  593-6     Citation Subset:  IM    
Spectrum Health Hospitals and College of Medicine, Michigan State University, Grand Rapids, Michigan 49503, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Choline / adverse effects
Dietary Supplements / adverse effects*
Folic Acid / administration & dosage*,  adverse effects
Neural Tube Defects / chemically induced*,  prevention & control*
Vitamin B Complex / administration & dosage*,  adverse effects
Reg. No./Substance:
12001-76-2/Vitamin B Complex; 59-30-3/Folic Acid; 62-49-7/Choline
Comment In:
Genet Med. 2011 Sep;13(9):849; author reply 849   [PMID:  21885925 ]

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Transformational Teaching and Physical Activity Engagement Among Adolescents.
Next Document:  Multiple endocrine neoplasia type 2: An overview.